{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:28:34Z","timestamp":1787930914209,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.farma.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:04:25Z","timestamp":1780085065000},"page":"T346-T356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Use of milrinone in the treatment of cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage: A narrative review"],"prefix":"10.1016","volume":"50","author":[{"given":"Irene","family":"Cavada Carranza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Esther","family":"Tejerina \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Molina Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Lorente Balanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2026.04.007_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1474-4422(09)70126-7","article-title":"Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis","volume":"8","author":"Nieuwkamp","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.farma.2026.04.007_bb0010","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1212\/WNL.0b013e3181dd42b3","article-title":"Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review","volume":"74","author":"Lovelock","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.farma.2026.04.007_bb0015","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.farma.2026.04.007_bb0020","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","article-title":"Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"54","author":"Hoh","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.farma.2026.04.007_bb0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","article-title":"Cerebral infarction after subarachnoid haemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects","volume":"42","author":"Vergouwen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.farma.2026.04.007_bb0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40120-022-00348-6","article-title":"Economic and humanistic burden of cerebral vasospasm and its related complications after aneurysmal subarachnoid haemorrhage: a systematic literature review","volume":"11","author":"Thompson","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.farma.2026.04.007_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12028-023-01713-5","article-title":"Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage","volume":"39","author":"Treggiari","year":"2023","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bja\/aes264","article-title":"Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm","volume":"109","author":"Rowland","year":"2012","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.farma.2026.04.007_bb0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/STROKEAHA.117.017956","article-title":"Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial","volume":"49","author":"Gathier","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.farma.2026.04.007_bb0050","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1212\/WNL.0000000000007862","article-title":"Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: more is more","volume":"93","author":"Jabbarli","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.farma.2026.04.007_bb0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12883-020-01792-3","article-title":"Angioplasty with the scepter C dual lumen balloon catheter and postprocedural result evaluation in patients with subarachnoid hemorrhage related vasospasms","volume":"20","author":"Tsogkas","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.farma.2026.04.007_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105590","article-title":"Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: a single center experience","volume":"188","author":"Schacht","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.farma.2026.04.007_bb0065","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.farma.2026.04.007_bb0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaneurol.2023.1792","article-title":"Effectiveness of lumbar cerebrospinal fluid drain among patients with aneurysmal subarachnoid hemorrhage: a randomized clinical trial","volume":"80","author":"Wolf","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.farma.2026.04.007_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5935\/0103-507X.20200097","article-title":"Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review","volume":"32","author":"Santos-Teles","year":"2020","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.farma.2026.04.007_bb0080","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s10143-021-01509-1","article-title":"Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review","volume":"44","author":"Castle-Kirszbaum","year":"2021","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.farma.2026.04.007_bb0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/cjn.2016.316","article-title":"The use of milrinone in patients with delayed cerebral ischemia following subarachnoid hemorrhage: a systematic review","volume":"44","author":"Lannes","year":"2017","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.farma.2026.04.007_bb0090","first-page":"1120","article-title":"Intravenous milrinone for delayed cerebral ischaemia in aneurysmal subarachnoid haemorrhage: a systematic review","volume":"38","author":"Lannon","year":"2024","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.farma.2026.04.007_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0163-7258(90)90060-F","article-title":"Cyclic AMP and mechanisms of vasolidation","volume":"47","author":"Murray","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.farma.2026.04.007_bb0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/01.NEU.0000363153.62579.FF","article-title":"Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone","volume":"66","author":"Nishiguchi","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.farma.2026.04.007_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/jcan.2002.29680","article-title":"Milrinone increases middle cerebral artery blood flow velocity after cardiopulmonary bypass","volume":"16","author":"Sulek","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.farma.2026.04.007_bb0110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/med.21270","article-title":"Myosin light chain kinase signaling in endothelial barrier dysfunction","volume":"33","author":"Rigor","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.farma.2026.04.007_bb0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.RES.0000091074.33584.F0","article-title":"Role of phosphodiesterase 3 in NO\/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells","volume":"93","author":"Aizawa","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.farma.2026.04.007_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(25)20961-2","article-title":"Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors","volume":"279","author":"Bergman","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.farma.2026.04.007_bb0125","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0003-4975(99)00716-X","article-title":"Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass","volume":"68","author":"Hayashida","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.farma.2026.04.007_bb0130","first-page":"723","article-title":"Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases","volume":"48","author":"Arakawa","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.farma.2026.04.007_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2176\/nmc.44.393","article-title":"Milrinone reduces cerebral vasospasm after subarachnoid hemorrhage of WFNS grade IV or V","volume":"44","author":"Arakawa","year":"2004","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.farma.2026.04.007_bb0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/STROKEAHA.107.492447","article-title":"Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"39","author":"Fraticelli","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.farma.2026.04.007_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12028-008-9048-0","article-title":"Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage","volume":"11","author":"Romero","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0150","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1213\/ANE.0b013e3181cc9ed8","article-title":"Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and\/or milrinone","volume":"110","author":"Schmidt","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.farma.2026.04.007_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00234-010-0720-7","article-title":"Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage","volume":"53","author":"Shankar","year":"2011","journal-title":"Neuroradiology"},{"key":"10.1016\/j.farma.2026.04.007_bb0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12028-012-9701-5","article-title":"Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol","volume":"16","author":"Lannes","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-319-04981-6_35","article-title":"Repeated combined endovascular therapy with milrinone and nimodipine for the treatment of severe vasospasm: preliminary results","volume":"120","author":"Sherif","year":"2015","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.farma.2026.04.007_bb0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/1591019917732288","article-title":"Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm","volume":"23","author":"Duman","year":"2017","journal-title":"Interv Neuroradiol"},{"key":"10.1016\/j.farma.2026.04.007_bb0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.egja.2013.07.006","article-title":"Effects of milrinone continuous intravenous infusion on global cerebral oxygenation and cerebral vasospasm after cerebral aneurysm surgical clipping","volume":"30","author":"Ghanem","year":"2014","journal-title":"Egyp J Anaesth"},{"key":"10.1016\/j.farma.2026.04.007_bb0180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00701-017-3104-5","article-title":"Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage","volume":"159","author":"Hej\u010dl","year":"2017","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.farma.2026.04.007_bb0185","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00701-022-05145-6","article-title":"Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"164","author":"Steiger","year":"2022","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.farma.2026.04.007_bb0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12028-021-01288-z","article-title":"Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage","volume":"36","author":"Rouanet","year":"2022","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0195","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: respective short-term effects of induced arterial hypertension and its combination with IV milrinone: a proof-of-concept study using transcranial Doppler ultrasound","volume":"5","author":"Lakhal","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.farma.2026.04.007_bb0200","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12028-014-9996-5","article-title":"Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage","volume":"21","author":"Sadamasa","year":"2014","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3171\/2016.10.JNS162227","article-title":"Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"128","author":"Koyanagi","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1016\/j.farma.2026.04.007_bb0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/ANA.0000000000000527","article-title":"Which protocol for milrinone to treat cerebral vasospasm associated with subarachnoid hemorrhage?","volume":"31","author":"Crespy","year":"2019","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1016\/j.farma.2026.04.007_bb0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3171\/2020.1.JNS193107","article-title":"Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia","volume":"134","author":"Abulhasan","year":"2020","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.farma.2026.04.007_bb0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12028-025-02260-x","article-title":"Treatment effect of early intravenous milrinone for cerebral vasospasm or delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"43","author":"Baang","year":"2025","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0225","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bjan.2018.09.005","volume":"69","author":"Soliman","year":"2019","journal-title":"Braz J Anesthesiol"},{"key":"10.1016\/j.farma.2026.04.007_bb0230","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12028-021-01331-z","article-title":"Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: the MILRISPASM controlled before-after study","volume":"35","author":"Lakhal","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12028-023-01738-w","article-title":"Hemodynamic management in the prevention and treatment of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"39","author":"Deem","year":"2023","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.farma.2026.04.007_bb0240","series-title":"Cerebral hemodynamic optimization by milrinone to prevent delayed cerebral ischemia (OPTIMIL)","author":"University Hospital, Toulouse","year":"2020"},{"key":"10.1016\/j.farma.2026.04.007_bb0245","series-title":"Milrinone infusion for vasospasm treatment in subarachnoid hemorrhage (MIVAR)","author":"University Hospital, Angers","year":"2020"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:08:33Z","timestamp":1787929713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634326001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1130634326001029"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.007","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Use of milrinone in the treatment of cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.02.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}